• search

Nectar Lifesciences raises USD 35 mn through FCCBs

Written by: Staff

Mumbai, Mar 24 (UNI) Nectar Lifesciences Ltd today successfully raised USD 35 million through foreign currency convertible bonds (FCCB).

Deutsche Bank acted as the sole bookrunner for the transaction.

The bonds, which have a maturity of five years and one day, are convertible at a conversion price of Rs 331.74 per share, which is at a premium of 20 per cent over the closing price of Rs 276.45 on the Bombay Stock Exchange today.

The bonds are zero coupon bonds with a yield to maturity of 8.375 per cent, calculated on a semi-annual basis, at the end of five years if not converted, into shares during this period, said a company release.

Due to the strong response to the offering, the issue was upsized from USD 30 million to USD 35 million.

The bonds are expected to be listed on the Singapore Exchange Securities Trading Limited.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more